Skip to main content
Premium Trial:

Request an Annual Quote

Additional Identifications

Next-generation sequencing has enabled the identification of two additional individuals who died in the 9/11 World Trade Center attack 20 years ago, the Washington Post reports.

According to the Post, about 40 percent of the people, or about 1,000 individuals, who died there that day have yet to be officially identified. It adds that the all the remains that have been collected have been tested and have been undergoing additional testing as new tools and technologies emerge.

"We continue to push the science out of necessity to make more identifications," Mark Desire, manager of the World Trade Center DNA Identification Team, says in a statement. "The commitment today is as strong as it was in 2001."

The newly identified individuals include Dorothy Morgan from Hempstead, NY, and a man whose family requested his name be withheld, according to the New York medical examiner's office. It adds that the identification of Morgan and the unnamed man were the first since 2019.

Nykiah Morgan, Dorothy Morgan' daughter, tells NBC New York she had accepted her mother's death, though did sometimes wonder if she was still out there. "Maybe she had amnesia. Maybe she's out living a whole different life and she's happy," she adds at NBC New York.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.